So, the depleted levels of GSH and catalase as a result of CMF therapy in tumor animals (p < 0.01) was restored by all the treatment groups but more significantly by the Mulmina treatment, MN-40 (p < 0.01) and MN-80 (p < 0.001) (Fig:8). The gene discussed is CAT; the disease is neoplasm.